Zobrazeno 1 - 10
of 1 771
pro vyhledávání: '"Fibrosis progression"'
Autor:
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Weiming Yan, Dong Xi, Meifang Han, Qin Ning, Hongwu Wang
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 7, Pp 773-780 (2024)
Background: The burden of nonalcoholic fatty liver disease (NAFLD) is growing in patients with chronic hepatitis B (CHB). NAFLD is typically associated with obesity, however, it is increasingly being identified in non-obese patients. This study aimed
Externí odkaz:
https://doaj.org/article/964daf74ae9c480e829ad354a2b37db9
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
AimThe correlation between type 2 diabetes mellitus (T2DM) and the occurrence of liver fibrosis is well-established. However, the longitudinal association between body composition and liver fibrosis progression in patients with T2DM remains incomplet
Externí odkaz:
https://doaj.org/article/ba0dceaaff864e36ab3f17cdd9a664c1
Autor:
Guangyuan Huo, Yueqiu Gao
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundThere has been controversy and uncertainty regarding the causal relationship between type 1 diabetes, its consequences, liver fibrosis, and cirrhosis. In order to determine the causal relationship, we conducted a Mendelian randomization stu
Externí odkaz:
https://doaj.org/article/1e9b87e16bae4a43bf9421de43440036
Autor:
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Weiming Yan, Dong Xi, Meifang Han, Qin Ning, Hongwu Wang
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e28653- (2024)
Background & aims: With a drastic increase in the number of chronic hepatitis B (CHB) patients with coexisting nonalcoholic fatty liver disease (NAFLD), there is an urgent need to evaluate antiviral treatment effects in this special population. Metho
Externí odkaz:
https://doaj.org/article/25925d8773534ccb81e195010448d1da
Autor:
Julia Peña-Asensio, Henar Calvo-Sánchez, Joaquín Miquel-Plaza, Eduardo Sanz-de-Villalobos, Alejandro González-Praetorius, Alberto Delgado-Fernandez, Miguel Torralba, Juan-Ramón Larrubia
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundHBe-antigen(Ag)-negative chronic hepatitis B virus (HBV) infection is characterized by little liver fibrosis progression and vigorous HBV-multispecific CD8+ T-cell response.AimsTo assess whether HBsAg level could discriminate different HBeA
Externí odkaz:
https://doaj.org/article/15262ea5052547689d84e817db95f44b
Publikováno v:
Journal of Education, Health and Sport, Vol 48, Iss 1 (2023)
Recently it has been established that cytokines are involved in the regulation of the body’s defense reactions in response to a pathogen and form an independent system for regulating homeostasis. The aim of this work is to study the relationship of
Externí odkaz:
https://doaj.org/article/07c655a3cb6b473f844b74149045a189
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 1777-1785 (2023)
Wei Xu,1,* Qiankun Hu,1,* Chong Chen,2,* Weixia Li,2 Qiang Li,1 Liang Chen1 1Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People’s Republic of China; 2Department of Infectious Disease,
Externí odkaz:
https://doaj.org/article/180a07b04df54ecdb2cb1ed48bc5c1a3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
The specific pathways, timescales, and dynamics driving the progression of fibrosis in NAFLD and NASH are not yet fully understood. Hence, a mechanistic model of the pathogenesis and treatment of fibrosis in NASH will necessarily have significant unc
Externí odkaz:
https://doaj.org/article/3051fb48e64a4ea79bba6d0b8696a938
Autor:
Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, Valentina Peta, Sepideh Akhavan, Fabien Zoulim, Victor de Ledinghen, Didier Samuel, Philippe Mathurin, Vlad Ratziu, Dominique Thabut, Chantal Housset, Hélène Fontaine, Stanislas Pol, Fabrice Carrat
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 4, Pp 604-617 (2022)
Background and Aims: The liver cancer risk test (LCR1-LCR2) is a multianalyte blood test combining proteins involved in liver cell repair (apolipoprotein A1, haptoglobin), hepatocellular carcinoma (HCC) risk factors (gender, age, gamma glutamyl trans
Externí odkaz:
https://doaj.org/article/fe0797793ffb4609867fca065acaaac8